In lung adenocarcinoma, pulmonary TLSs that contain GCs are CXCL13‐dependent and generate cancer‐specific antibodies against endogenous retroviruses that are expressed by the cancerous cells [117]. This evidence concerns the gene CXCL13 and cancer.